Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study
Therapeutic Advances in Psychopharmacology · 2022-01 · 12
DOI: 10.1177/20451253221122526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 08.10.2022. Verfasst von Cristiana Montemagni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience 'Rita Levi Montalcini', University of Turin, AOU Città della Salute e della Scienza, Via Cherasco N. 15, 10126 Turin, Ital…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Partial adherence to antipsychotics is the most common cause of relapses and rehospitalization in patients with schizophrenia (SZ), leading to higher health care costs and psychosocial disability. The use of long-acting injectable (LAI) antipsychotics may improve therapeutic continuity and adherence to treatment.
Objective
To assess the effectiveness of switching from oral antipsychotics (OAs) to long-acting antipsychotics.
Methods
This 1-year mirror-image study evaluated the effect of switching from OAs to LAIs on the reduction of psychiatric hospitalizations and the improvement of global functioning in patients with schizophrenia. Differences in outcomes between second-generation (SGA) LAIs and first-generation (FGA) LAIs were also analyzed.
Results
In all, 166 patients were included: 32.5% treated by FGA-LAIs and 67.5% by SGA-LAIs. There was an overall reduction of 71% in the average number of hospital admissions and an overall improvement of 29.3% in the Global Assessment of Functioning (GAF) score between the previous 12 months and the 12 months following the switching to LAIs. Patients who switched to SGA-LAIs had no significant differences in hospitalization occurrences but a significant improvement in GAF scores when compared with patients who switched to FGA-LAIs.
Conclusion
Our results suggest that using LAIs could be the most adequate treatment choice for SZ patients with a high risk of relapse and low adherence rate. Patients with poorer social functioning may be ideal candidates for SGA-LAIs treatment. Our findings may be of particular interest from a clinical and health care management perspective.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, AOU Città della Salute e della Scienza, Via Cherasco N. 15, 10126 Turin, Italy.
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.
- Department of Mental Health, Azienda Sanitaria Locale (ASL) Città di Torino, Turin, Italy.
ORCID-Profile: Cristiana Montemagni
Zitieren
APA
Montemagni, C., Del Favero, E., Cocuzza, E., Vischia, F., & Rocca, P. (2022). Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221122526
Vancouver
Montemagni C, Del Favero E, Cocuzza E, Vischia F, Rocca P. Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study. Therapeutic Advances in Psychopharmacology. 2022;12. doi:10.1177/20451253221122526
BibTeX
@article{Montemagni2022,
author = {Montemagni, Cristiana and Del Favero, Elisa and Cocuzza, Elena and Vischia, Flavio and Rocca, Paola},
title = {Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2022},
volume = {12},
doi = {10.1177/20451253221122526}
}
EUVIMED